肠易激综合症 (IBS) 诊断市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00016657
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 185
Buy Now

2020 年肠易激综合征 (IBS) 诊断市场价值为 24.7061 亿美元,预计到 2028 年将达到 388091 万美元;预计 2021 年至 2028 年复合年增长率为 5.9%。

肠易激综合症 (IBS) 被定义为一种胃肠道疾病,导致肠道不适胃痛,同时伴有腹泻、便秘。由细菌或病毒引起的严重腹泻(胃肠炎)后可能会出现肠易激综合症。 IBS 也可能与肠道细菌过多(细菌过度生长)有关。经历过压力事件的人,尤其是在童年时期,往往会出现更多肠易激综合症的症状。 IBS 诊断是通过病史、体格检查和影像学检查来完成的。然而,肠易激综合症主要通过乳糖不耐症测试、细菌过度生长的呼气测试、血液测试和粪便测试来诊断。这些测试是根据便秘为主、腹泻为主或混合等症状进行的。它还可以通过各种影像学检查(如 CT 扫描或 X 射线、上消化道内窥镜检查和结肠镜检查)进行检测。

肠易激综合征 (IBS) 诊断市场是根据诊断、适应症和地理进行细分。按地域划分,市场分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美洲和中美洲。该报告提供了肠易激综合症(IBS)诊断市场的见解和深入分析,重点介绍了市场趋势、技术进步和市场动态等参数,并分析了全球领先市场参与者的竞争格局。  

肠易激综合症(IBS)诊断市场

市场洞察
肠易激综合症是一种慢性胃肠道疾病,由排便习惯紊乱和腹痛引起。该病也称为痉挛性结肠、结肠激惹、粘液性结肠炎和痉挛性结肠炎。肠易激综合症表现为腹痛、便秘、腹泻和痉挛等症状。

世界各地的人们都目睹了肠易激综合症的发病率相当高。根据国际胃肠道疾病基金会公布的数据,在所有肠易激综合征患者中,约40%的人患有轻度IBS,约35%的人患有中度IBS,估计25%的人患有重度IBS。食物过敏、胃肠炎发展阶段、结肠不规则运动、结肠中血清素成分异常以及轻度乳糜泻都是导致肠易激综合征的危险因素。根据 NCBI 2018 年发表的一项研究,肠易激综合症估计每年影响约 10-16% 的美国人口。此外,根据 IBS 全球影响报告,2016 年各个国家的平均患病率估计为法国和伊朗的 1.1% 到墨西哥的 35.5%。拉丁美洲的患病率为 17.5%,亚洲为 9.6%,北美/欧洲/澳大利亚/新西兰为 7.1%,中东和非洲为 7.1%。非洲的患病率为 5.8%。肠易激综合症如此惊人的患病率可能会在预测期内推动肠易激综合症 (IBS) 诊断市场的发展。

为了应对肠易激综合症,市场参与者正在采取建设性措施来制定计划在民众中传播意识。例如,2018 年,Allergan PLC 和 Ironwood 合作推出了交互式数字目的地平台,鼓励患者接受教育并采取行动。同样,2018 年 1 月,Commonwealth Diagnostics International, Inc. 与美国职业高尔夫球手 Rob Oppenheim 合作,提高人们对肠易激综合征 (IBS) 和小肠细菌过度生长 (SIBO) 的认识。

FDA 数量不断增加批准和诊断开发对市场增长做出重大贡献

FDA 批准和诊断开发活动数量的增加可能会在预测期内加速肠易激综合征 (IBS) 诊断市场的增长。大多数老牌和新玩家都在积极开发和制造该疾病的诊断解决方案,这将导致市场上有充足的诊断解决方案。例如,2020 年 2 月,Commonwealth Diagnostics International (CDI), Inc. 重新推出了 IBSchek,这是针对混合型肠易激综合征(IBS-D、IBS-M)和腹泻为主的第一个经过临床验证的生物标志物血液检测。一种新的家用毛细管采集套件。此外,2018 年 10 月,Gemelli Biotech 与 Cedars-Sinai 的医学相关科学技术计划 (MAST) 合作推出了 IBS-smart,这是肠易激综合征 (IBS) 血液检测的一项创新技术。

预计肠易激综合症(IBS)诊断市场将见证诊断解决方案的批准,这最终将对市场的增长产生积极影响。例如,2019 年 6 月,BüHLMANN Laboratories AG 的 BüHLMANN fCAL Turbo 自动钙卫蛋白测试和 BüHLMANN fCAL ELISA 钙卫蛋白测试获得美国食品和药物管理局 (FDA) 510(k) 许可。据公司估计,该测试预计将观察全球市场的蓬勃销售。

诊断见解          

根据诊断,全球肠易激综合征(IBS)诊断市场分为实验室测试和影像学测试。 2020年,实验室测试领域占据了最大的市场份额。此外,预计到 2028 年,该细分市场将占据最大的市场份额。市场增长主要归因于全球范围内肠易激综合症 (IBS) 的患病率不断上升,由于排便习惯的紊乱和肠道菌群失调,这种情况可能会在未来几年持续下去。腹痛。这反过来又增加了全世界对这些疾病的诊断需求。

             ;            

适应症洞察

根据适应症,全球肠易激综合征(IBS)诊断市场分为疼痛和痉挛、腹泻、便秘以及便秘和腹泻交替。疼痛和痉挛细分市场在 2020 年占据最大的市场份额,预计到 2028 年将主导市场。解痉药和抗抑郁药是用于治疗 IBS 疼痛和痉挛的药物。    

肠易激综合症(IBS)诊断市场(按治疗) 2020 年和 2028 年

战略洞察

产品发布和并购是全球肠易激综合征 (IBS) 诊断市场广泛采用的策略。下面列出了近期的一些关键产品开发:

2020 年 2 月,Commonwealth Diagnostics International (CDI), Inc. 宣布重新推出 IBSchek 的商业版,第一个经过临床验证的针对腹泻型和混合型肠易激综合征(IBS-D、IBS-M)的生物标志物血液检测,采用新型家用毛细血管采集套件进行。

 

2019 年 1 月,Gemelli Biotech 宣布与总部位于科威特的 Advanced Medical German Co. (AMG) 建立合作伙伴关系,该公司是中东地区领先的医疗产品和服务国际分销商之一。通过此次合作,AMG 将在中东和北非的主要地区(包括科威特、阿联酋、卡塔尔、沙特阿拉伯、埃及和土耳其)分销 Gemelli 专有的 IBS 诊断血液测试 ibs-smart。

据估计,COVID-19 大流行将对肠易激综合征 (IBS) 诊断市场产生重大积极影响。全球大多数制药公司都在从事 COVID-19 疫苗的开发。此外,肠易激综合症 (IBS) 经常由 COVID-19 压力引发。因此,家庭检测套件比实验室检测更可取,因为实验室服务可能在大流行中不堪重负,预计这将在未来几个月对市场的其他领域产生积极影响。然而,由于全球运营停止而造成的供应链中断正在阻碍市场增长。

肠易激综合症 (IBS) 诊断 –市场细分

按诊断

  • 实验室测试
    • 乳糖不耐受测试
    • 呼吸测试细菌过度生长
    • 粪便测试
    • 血液测试
  • 影像学测试
    • CT扫描或X射线
    • 上消化道内窥镜检查
    • 结肠镜检查

按适应症

  • 疼痛和痉挛
  • 腹泻
  • 便秘
  • 便秘和腹泻交替

按地理位置划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国< /li>
    • 德国
    • 英国
    • 意大利
    • 西班牙
    • 欧洲其他地区
    < /li>
  • 亚太地区 (APAC)
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 南部韩国
    • 亚太地区其他地区
  • 中东和中东地区非洲 (MEA)
    • 沙特阿拉伯
    • 南非
    • 阿联酋
    • 中东其他地区和地区非洲
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 中南美洲其他地区美国

公司简介

  • Commonwealth Diagnostics International
  • Genova Diagnostics
  • Gemelli Biotech
  • Prometheus Laboratories
  • Inova Diagnostics, Inc.
  • Biohit Oyj
  • Aerodiagnostics, LLC.
  • Metabolic Solutions, Inc.
  • Sysmex Corporation
  • Bühlmann Laboratories AG
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is irritable bowel syndrome (IBS) diagnostics?

Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhoea and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. Moreover, IBS diagnostics is done through medical history, physical exam and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test and stool test. The tests are done based on the symptoms such as constipation-predominant, diarrhea-predominant or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy and colonoscopy.

What are the driving factors for the irritable bowel syndrome (IBS) diagnostics market across the globe?

The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are anticipated to drive the growth of the global irritable bowel syndrome (IBS) diag nostics market during the forecast period. However, challenges in diagnosis of IBS are hindering the market growth.

Who are the major players in the irritable bowel syndrome (IBS) diagnostics market?

The irritable bowel syndrome (IBS) diagnostics market majorly consists of the players such Commonwealth Diagnostics International, Genova Diagnostics, Gemelli Biotech, Prometheus Laboratories, Inova Diagnostics, Inc., Biohit Oyj, Aerodiagnostics, LLC., Metabolic Solutions, Inc., Sysmex Corporation, BÃœHLMANN Laboratories AG are among others.

The List of Companies - Irritable Bowel Syndrome (IBS) Diagnostics Market

  1. Commonwealth Diagnostics International
  2. Genova Diagnostics
  3. Gemelli Biotech
  4. Prometheus Laboratories
  5. Inova Diagnostics, Inc.
  6. Biohit Oyj
  7. Aerodiagnostics, LLC.
  8. Metabolic Solutions, Inc.
  9. Sysmex Corporation
  10. BÜHLMANN Laboratories AG.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports